March 11th, 2013
Horizon Gazing: Blogging from ACC.13
Jeremiah Depta, MD
Novel approaches to training, medical innovation, and clinical practice
March 11th, 2013
Selections from Richard Lehman’s Literature Review: March 11th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include antiplatelet therapy to prevent CV events and mortality in those with intermittent claudication, endovascular treatment for stroke, and more.
March 11th, 2013
Diversity in Cardiology: Blogging from ACC.13
Tariq Ahmad, MD, MPH
What can be done to increase the numbers of women and minorities at ACC.13 and in cardiology in general?
March 11th, 2013
The Human Touch After Hours and Between Sessions: Blogging from ACC.13
Tariq Ahmad, MD, MPH
Much of medical training in spent paying respect to a strict hierarchy, and these meetings allow for mentors and mentees to interact as peers.
March 11th, 2013
Devices vs. Drugs: A Distinction Without a Difference? Blogging from ACC.13
Sandeep Mangalmurti, MD, JD
How are devices regulated? Due to some quirks, the tail now wags the dog.
March 11th, 2013
Hoping for Good Data from Partner II B: Blogging from ACC.13
Megan Coylewright, MD MPH
Walking the walk on TAVR
March 10th, 2013
Was Atherosclerosis the Real Curse of the Mummy?
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. From a growing evidence base of mummies, researchers are now concluding that atherosclerosis may have been common in […]
March 10th, 2013
Another Negative Trial of Darbepoetin Alfa
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. Once again a trial testing the erythropoiesis-stimulating agent darbepoetin alfa (Aranesp, Amgen) has produced a negative result. Results […]
March 10th, 2013
A Renaissance for the Poster: Blogging from ACC.13
Kumar Dharmarajan, MD MBA
Putting the posters in the Expo Hall pays off
March 10th, 2013
Eplerenone May Help Prevent Heart Failure in Acute STEMI Patients
Larry Husten, PHD
For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. A new trial presented at the ACC in San Francisco suggests that the mineralocorticoid-receptor antagonist eplerenone (Pfizer, Inspra) […]